Clever Leaves Holdings Inc. (CLVR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 17.41 Million USD | -2.15% |
| 2022 | 17.8 Million USD | 15.78% |
| 2021 | 15.37 Million USD | 26.88% |
| 2020 | 12.11 Million USD | 54.67% |
| 2019 | 7.83 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q2 | 4.98 Million USD | 25.21% |
| 2023 Q1 | 3.97 Million USD | -13.78% |
| 2023 Q3 | 3.82 Million USD | -23.31% |
| 2023 Q4 | 4.63 Million USD | 21.41% |
| 2023 FY | 17.41 Million USD | -2.15% |
| 2022 Q4 | 4.61 Million USD | 60.93% |
| 2022 Q3 | 2.86 Million USD | -30.07% |
| 2022 FY | 17.8 Million USD | 15.78% |
| 2022 Q2 | 4.1 Million USD | -21.52% |
| 2022 Q1 | 5.22 Million USD | 24.56% |
| 2021 FY | 15.37 Million USD | 26.88% |
| 2021 Q4 | 4.19 Million USD | 4.04% |
| 2021 Q3 | 4.03 Million USD | 9.78% |
| 2021 Q2 | 3.67 Million USD | 5.61% |
| 2021 Q1 | 3.47 Million USD | 3.88% |
| 2020 Q4 | 3.34 Million USD | -14.55% |
| 2020 Q3 | 3.91 Million USD | 102.01% |
| 2020 Q2 | 1.93 Million USD | -33.46% |
| 2020 Q1 | 2.91 Million USD | 11.09% |
| 2020 FY | 12.11 Million USD | 54.67% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 7.83 Million USD | 0.0% |
| 2019 Q3 | 3.05 Million USD | 41.92% |
| 2019 Q4 | 2.62 Million USD | -14.2% |
| 2019 Q2 | 2.15 Million USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Bright Green Corporation | 401.49 Thousand USD | -4238.08% |
| BioQuest Corp. | - USD | -Infinity% |
| Eagle Pharmaceuticals, Inc. | 316.61 Million USD | 94.499% |
| Guardion Health Sciences, Inc. | 12.24 Million USD | -42.196% |
| GSRX Industries Inc. | - USD | -Infinity% |
| High Sierra Technologies, Inc. | - USD | -Infinity% |
| Instadose Pharma Corp. | - USD | -Infinity% |